AstraZeneca criticised for 'Golden Hello' compensation agreement -...
Pharmaceutical company, AstraZeneca, have come under fire after paying its new chief executive £6.5m for three months work last year. The Local Authority Pension fund Forum (LAPFF), one of Britain’s...
View ArticleAbbVie to hack hundreds of reps from cardiovascular sales ranks - FiercePharma
via fiercepharma.com Permalink | Leave a comment »
View ArticleGlaxo accused of pay delay -- Yorkshire Post
via yorkshirepost.co.uk Drugs giant GlaxoSmithKline was today accused by the competition watchdog of paying off firms to delay the launch of cheap versions of its antidepressant treatment in a move...
View ArticleJury awards $63M to Samantha Reckis, girl who lost skin after taking Motrin -...
via cbsnews.com BOSTONA jury has awarded a Massachusetts teenager and her parents $63 million nearly a decade after she suffered a life-threatening drug reaction that caused her to lose most of her...
View ArticleClinical trials of drugs in India plummet - The New Indian Express
via newindianexpress.com http://newindianexpress.com/nation/Clinical-trials-of-drugs-in-India-plummet/...? Permalink | Leave a comment »
View ArticleCatch-22, Clinical Trial Edition: The Double Bind for Women and Children |...
via blogs.scientificamerican.com http://blogs.scientificamerican.com/guest-blog/2013/04/23/catch-22-clinical-t... Permalink | Leave a comment »
View ArticleNovartis changes CFOs, reveals cuts to work force and chairman pay -...
via fiercebiotech.com http://www.fiercebiotech.com/story/novartis-switches-cfos-reveals-cuts-work-f... Permalink | Leave a comment »
View ArticleAstraZeneca UK plant under US investigation
via cheshire-today.co.uk Macclesfield’s AstraZeneca plant is being investigated by US authorities, it emerged today. The pharmaceutical giant issued a terse statement alongside its first quarter...
View ArticleTrying to Burnish Its Image, Johnson & - Johnson Turns to Emotions
The company’s McNeil Consumer Healthcare unit recalled more than 280 million packages of over the counter medications like Motrin, children’s Tylenol liquid and Benadryl in 2010, and the same year,...
View ArticleDocs call drugmakers 'profiteers' for costs of cancer meds - FiercePharma
via fiercepharma.com The doctors called out as an example, Novartis' ($NVS) Gleevec, a treatment for chronic myeloid leukemia. They pointed out that it came on the market at a cost of $30,000 a year...
View ArticleHow academic medicine's Gold Standard has lead to disease mongering
via davidhealy.org Permalink | Leave a comment »
View ArticleU.S. files second lawsuit accusing Novartis of kickbacks
via dailypress.com The government accused Novartis of causing the Medicare and Medicaid programs to pay millions of dollars in reimbursements based on kickback-tainted claims for drugs such as...
View ArticlePsychedelics eyed for mood disorders - Boing Boing
via boingboing.net Permalink | Leave a comment »
View ArticleDrugs deal wastes $260m
via brisbanetimes.com.au The government is wasting $260 million every year because it is ignoring advice that it is paying too much for the most commonly prescribed drug in Australia. Health...
View ArticleDid Novartis Violate A Corporate Integrity Agreement? | Pharmalot
via pharmalive.com Permalink | Leave a comment »
View ArticleDrug industry ‘profiteering’ threatens lives, say doctors - Telegraph
via telegraph.co.uk Some 11 of the 12 drugs approved by the Food and Drug Administration in the US in 2012 were priced above $100,000 (£65,000) per patient per year, with the price of existing drugs...
View ArticleNovartis speaks out after second kickbacks lawsuit
>via pharmatimes.com The lawsuits also noted one dinner for three, including the speaker, at a Washington DC restaurant which cost over $2,000. At another programme held on Valentine’s Day in 2006,...
View ArticleValeant-Actavis talks break down - The Globe and Mail
via theglobeandmail.com Permalink | Leave a comment »
View ArticleEditorial :: It's time for AllTrials registered and reported - The Cochrane...
It's time for AllTrials registered and reported By: Tracey Brown On: April 30, 2013, 12:53 The Cochrane Collaboration has become a lead partner in the AllTrials initiative (AllTrials.net), a campaign...
View ArticleEuropean Medicines Agency receives interim decisions of the General Court of...
via ema.europa.eu Permalink | Leave a comment »
View Article
More Pages to Explore .....